Tumor-infiltrating lymphocytes as a feasible adjuvant immunotherapy for osteosarcoma with a poor response to neoadjuvant chemotherapy

被引：17
|
作者：
Shi, Jing [1 ]
Li, Ming [1 ]
Yang, Rongzhi [1 ]
机构：
[1] Zhengzhou Univ, Dept Orthoped Surg, Luoyang Cent Hosp, Luoyang 471009, Peoples R China
来源：
IMMUNOTHERAPY | 2020年 / 12卷 / 09期
关键词：
adjuvant chemotherapy; adverse effects; immunotherapy; osteosarcoma; PD1; phenotype; poor response; prognostic factor; retrospective; TILs; SOUTHWEST-ONCOLOGY-GROUP; HIGH-GRADE OSTEOSARCOMA; METASTATIC MELANOMA; T-CELLS; NONMETASTATIC OSTEOSARCOMA; PROGNOSTIC-FACTORS; EWINGS-SARCOMA; OSTEO-SARCOMA; PHASE-II; CANCER;
D O I：
10.2217/imt-2020-0107
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Aim: To investigate the efficacy of adjuvant chemotherapy plus tumor-infiltrating lymphocytes (TILs) therapy in osteosarcoma patients with a poor response to neoadjuvant chemotherapy. Materials & methods: 40 patients received adjuvant chemotherapy (Group 1) and 40 patients received adjuvant chemotherapy plus TILs therapy (Group 2). Disease-free survival (DFS) and overall survival (OS) were analyzed by Kaplan-Meier analysis. Results: The median DFS (mDFS; 65.3 months) and median OS (mOS; 95.8 months) in Group 2 were significantly prolonged compared with those in Group 1 (55.5 months for mDFS and 80.4 months for mOS). Univariate and multivariate analyses indicated that a greater number of TILs transfused was an independent prognostic factor for both mDFS and mOS. Conclusion: Adjuvant chemotherapy plus TILs therapy may prolong survival of patients with a poor response to neoadjuvant chemotherapy.
引用
收藏
页码：641 / 652
页数：12
相关论文
共 50 条
  • [1] Tumor-Infiltrating Lymphocytes Predict Response to Neoadjuvant Chemotherapy in Patients with Breast Carcinoma
    Hornychova, Helena
    Melichar, Bohuslav
    Tomsova, Marketa
    Mergancova, Jindiska
    Urminska, Hana
    Ryska, Ales
    [J]. CANCER INVESTIGATION, 2008, 26 (10) : 1024 - 1031
  • [2] Significance of tumor-infiltrating lymphocytes in breast cancer with neoadjuvant chemotherapy
    Miyoshi, Y.
    Shien, T.
    Omori, M.
    Abe, Y.
    Watanabe, A.
    Hara, A.
    Mizoo, T.
    Nogami, T.
    Taira, N.
    Doihara, H.
    [J]. BREAST, 2015, 24 : S124 - S124
  • [3] Predictive value of tumor-infiltrating lymphocytes for response to neoadjuvant chemotherapy and breast cancer prognosis
    Li, Xiaomin
    Tan, Qiuwen
    Li, Hongjiang
    Yang, Xiaoqin
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 2021, 123 (01) : 89 - 95
  • [4] Tumor-infiltrating lymphocytes for melanoma immunotherapy
    Kepp, Oliver
    Liu, Peng
    Zitvogel, Laurence
    Kroemer, Guido
    [J]. ONCOIMMUNOLOGY, 2023, 12 (01):
  • [5] Tumor-infiltrating lymphocytes in the immunotherapy era
    Sterre T. Paijens
    Annegé Vledder
    Marco de Bruyn
    Hans W. Nijman
    [J]. Cellular & Molecular Immunology, 2021, 18 : 842 - 859
  • [6] Tumor-infiltrating lymphocytes in the immunotherapy era
    Paijens, Sterre T.
    Vledder, Annege
    de Bruyn, Marco
    Nijman, Hans W.
    [J]. CELLULAR & MOLECULAR IMMUNOLOGY, 2021, 18 (04) : 842 - 859
  • [7] The effect of neoadjuvant chemotherapy on tumor-infiltrating lymphocytes in patients with breast cancer
    Ilgun, Ahmet Serkan
    Aktepe, Fatma
    Gonullu, Onur
    Kapucuoglu, Nilgun
    Yararbas, Kanay
    Alco, Gul
    Ozturk, Alper
    Celebi, Filiz Elbuken
    Erdogan, Zeynep
    Ordu, Cetin
    Unal, Caglar
    Duymaz, Tomris
    Soybir, Gursel
    Yavuz, Ekrem
    Tuzlali, Sitki
    Ozmen, Vahit
    [J]. FUTURE ONCOLOGY, 2022, 18 (29) : 3289 - 3298
  • [8] Tumor-infiltrating lymphocytes are correlated with response to neoadjuvant chemotherapy in triple-negative breast cancer
    Ono, Makiko
    Tsuda, Hitoshi
    Shimizu, Chikako
    Yamamoto, Sohei
    Shibata, Tatsuhiro
    Yamamoto, Harukaze
    Hirata, Taizo
    Yonemori, Kan
    Ando, Masashi
    Tamura, Kenji
    Katsumata, Noriyuki
    Kinoshita, Takayuki
    Takiguchi, Yuichi
    Tanzawa, Hideki
    Fujiwara, Yasuhiro
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2012, 132 (03) : 793 - 805
  • [9] Tumor-infiltrating lymphocytes are correlated with response to neoadjuvant chemotherapy in triple-negative breast cancer
    Makiko Ono
    Hitoshi Tsuda
    Chikako Shimizu
    Sohei Yamamoto
    Tatsuhiro Shibata
    Harukaze Yamamoto
    Taizo Hirata
    Kan Yonemori
    Masashi Ando
    Kenji Tamura
    Noriyuki Katsumata
    Takayuki Kinoshita
    Yuichi Takiguchi
    Hideki Tanzawa
    Yasuhiro Fujiwara
    [J]. Breast Cancer Research and Treatment, 2012, 132 : 793 - 805
  • [10] Prediction of Treatment Response to Neoadjuvant Chemotherapy in Breast Cancer by Subtype Using Tumor-infiltrating Lymphocytes
    Asano, Yuka
    Kashiwagi, Shinichiro
    Goto, Wataru
    Takada, Koji
    Takahashi, Katsuyuki
    Hatano, Takaharu
    Takashima, Tsutomu
    Tomita, Shuhei
    Motomura, Hisashi
    Ohsawa, Masahiko
    Hirakawa, Kosei
    Ohira, Masaichi
    [J]. ANTICANCER RESEARCH, 2018, 38 (04) : 2311 - 2321
12345